In the SUSTAIN 6 CV outcomes trial (CVOT), once-weekly semaglutide (0.5 or 1.0 mg) added to standard of care significantly reduced the occurrence of a first major adverse CV event (MACE: CV death, nonfatal myocardial infarction [MI], or nonfatal stroke) vs placebo over 2 years in 3297 subjects with T2D and high CV risk [12]
Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW
Note that there are many other options available, and we encourage you to research which products may be right for you
Insurance and Cost: Navigating Financial Aspects Wondering about "zepbound cost" and whether insurance will cover it
I lost 9 lbs in the first month without altering my diet
One study specifically identified the infection as a risk factor of cardiovascular disease development in elderly G6PD-deficient patients [51]